Business Wire - Taro Receives FDA Approval for Alclometasone Dipropionate Cream USP, 0.05% ANDA; Tentative ANDA Approval Received for Gabapentin Capsules in 3 Strengths
September 16, 2005 -- HAWTHORNE, N.Y. -- Taro Pharmaceutical Industries Ltd. ("Taro," Nasdaq: TARO) reported today that Taro Pharmaceuticals U.S.A., Inc....